Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Photobiotics logo — Innovative solutions for precise MRI imaging and cancer trea...

Photobiotics

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and light-activated therapies

Founded 2001 1 employees Series Unknown Total: $390.00K Biotechnology, Life Sciences +1

General Information

Company Name Photobiotics
Founded Year 2001
Employees 1
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Photobiotics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Photobiotics

Photobiotics is a biotechnology and pharmaceutical startup founded in 2001, focusing on developing innovative solutions for precise MRI imaging and cancer treatment. Their flagship product, OptiLink, is a platform designed to attach multiple drugs to antibody fragments, thereby enhancing drug delivery for both imaging and therapy purposes. Furthermore, they have a diverse portfolio that includes antibody-drug conjugates and ProstaLite, a targeted light-activated solution for cancer therapy. The company recently secured a £390.00KVenture Round investment on 11 May 2010, signaling investor confidence in their pioneering approach to cancer treatment and imaging technologies. Photobiotics’ ability to leverage advanced drug delivery mechanisms and light-activated therapies aligns with the growing demand for more effective and precise solutions in the field of oncology and medical imaging. Their commitment to developing specialized therapies demonstrates potential for addressing critical challenges in cancer treatment, potentially positioning them as a valuable player in the pharmaceutical and biotechnology industries. With the continued support of investors, Photobiotics has the opportunity to further advance their innovative solutions and solidify their presence in the market.

Taxonomy: MRI imaging, cancer treatment, drug delivery, antibody fragments, therapeutics, conjugation platform, targeted therapies, antibody-drug conjugates, light-activated therapy, precision medicine, oncology, biopharmaceuticals, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 11 May 2010

Photobiotics Alternatives & Competitors

Photobiotics vs
Novelogics Biotechnology Inc.
Novelogics Biotechnology Inc. Canada

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
Photobiotics vs
Mablink Bioscience
Mablink Bioscience

Pioneering a new era in cancer therapy with innovative Antibody Drug Conjugates.

Series A
Biotechnology, Pharmaceutical
Photobiotics vs
Fortis Therapeutics
Fortis Therapeutics

Pioneering antibody-drug conjugate therapies to combat late-stage multiple myeloma and prostate canc...

Series A
Biotechnology, Health and Wellness

FAQ About Photobiotics

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and light-activated therapies
Photobiotics was founded in 2001.
Photobiotics operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Photobiotics has approximately 1 employees.
Photobiotics has completed 1 funding round, raising a total of $390.00K. The latest funding stage is Series Unknown.
Top alternatives and competitors to Photobiotics include Novelogics Biotechnology Inc., Mablink Bioscience, Fortis Therapeutics, Dima Biotechnology, Eureka Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Photobiotics and Novelogics Biotechnology Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Photobiotics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy